Exelixis | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Amgen USD 26.73B 195M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Bayer EUR 33.75B 1.08B 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Cytokinetics USD 886.54M 69.51M 2025-06
Eisai JPY 763.15B 35.49B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Exelixis USD 1.18B 215.74M 2025-07
Genmab DKK 3.91B 127M 2025-06
Glaxosmithkline GBP 17B 301M 2024-12
Incyte USD 3.64B 411.91M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 37.07B 1.56B 2025-06
Moderna USD 6.17B 595M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Sanofi 42.59B 12.51B 2024-12
Takeda JPY 2.51T 8.07B 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Xencor USD 513.15M 8.12M 2025-06


Exelixis Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.